GALEXOS DIN 02416441
Health Canada record
| Active ingredient(s) | SIMEPREVIR (SIMEPREVIR SODIUM) 150 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J05AP05 SIMEPREVIR |
| Original market date | 25-Nov-2013 |
| Current status date | 31-Mar-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14908 | 2013-11-18 | New Drug Submission (NDS) |